$179.50
2.991.69%
In chiusura: -
$179.50
N/A
After hour: Nov 7, 4:00 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Quest Diagnostics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Quest Diagnostics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Quest Diagnostics Inc addetti ai lavori?
A Quest Diagnostics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 1.48K azioni del valore di $270.32K, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno ottobre 24, 2025, Gary M Pfeiffer, l'azienda DIRECTOR sold 1.48K condivisioni per $182.4 ciascuna.
- Il giorno agosto 19, 2025, Patrick Plewman, l'azienda SVP FOR DIAGNOSTIC SERVICES sold 1.98K condivisioni per $180 ciascuna.
- Il giorno agosto 25, 2025, Patrick Plewman, l'azienda SVP FOR DIAGNOSTIC SERVICES sold 1.98K condivisioni per $185 ciascuna.
Statistiche sulla proprietà per Quest Diagnostics Inc
Numero di azioni emesse
111.242M
Azioni possedute dagli insider
2.111M
Percentuale posseduta dagli Insider
1.90%
Azioni possedute dagli investitori istituzionali
85.229M
Percentuale posseduta dagli investitori istituzionali
76.6%
Oct 24, 2025 | DIRECTOR | -1.48K | $182.40 | -$270.32K | SELL | -4.79% | 29.43K | Oct 22 | ||
Sep 30, 2025 | SVP & GENERAL COUNSEL | 0.00 | $145.85 | -$19.20K | SELL-OPTIONS | 0.00% | 43.81K | Sep 26 | ||
Sep 25, 2025 | SVP & GENERAL COUNSEL | 0.00 | $145.35 | -$2.38M | SELL-OPTIONS | 0.00% | 43.81K | Sep 23 - Sep 24 | ||
Aug 25, 2025 | SVP FOR DIAGNOSTIC SERVICES | -1.98K | $185.00 | -$365.38K | SELL | -11.45% | 15.27K | Aug 21 | ||
Aug 21, 2025 | SVP FOR DIAGNOSTIC SERVICES | 0.00 | $147.59 | -$321.00K | SELL-OPTIONS | 0.00% | 17.24K | Aug 19 | ||
Aug 19, 2025 | SVP FOR DIAGNOSTIC SERVICES | -1.98K | $180.00 | -$355.50K | SELL | -10.28% | 17.24K | Aug 15 | ||
Aug 08, 2025 | SVP FOR DIAGNOSTIC SERVICES | -1.98K | $130.81 | -$660.22K | SELL | -9.32% | 19.22K | Aug 06 | ||
Aug 01, 2025 | SVP, CLINICAL SOLUTIONS | -2.21K | $135.36 | -$910.17K | SELL | -17.98% | 10.08K | Jul 30 - Jul 31 | ||
May 14, 2025 | SVP & CHIEF COMMERCIAL OFFICER | -1.75K | $175.51 | -$306.80K | SELL | -18.91% | 7.50K | May 12 - May 13 | ||
Apr 04, 2025 | CEO AND PRESIDENT | -39.19K | $168.46 | -$6.60M | SELL | -23.49% | 127.62K | Apr 02 | ||
Apr 04, 2025 | SVP, CLINICAL SOLUTIONS | -2.56K | $170.00 | -$434.35K | SELL | -17.33% | 12.19K | Apr 02 | ||
Mar 19, 2025 | SVP & GENERAL COUNSEL | -4.64K | $170.00 | -$789.31K | SELL | -9.59% | 43.76K | Mar 17 | ||
Mar 07, 2025 | EVP, REGIONAL BUSINESSES | -5.37K | $174.13 | -$935.08K | SELL | -6.90% | 72.50K | Mar 05 | ||
Mar 05, 2025 | EVP, REGIONAL BUSINESSES | 4.26K | $173.86 | $738.66K | GRANT | 5.79% | 77.86K | Mar 03 - Mar 04 | ||
Mar 05, 2025 | SVP & GENERAL COUNSEL | 3.73K | $173.87 | $646.66K | GRANT | 8.35% | 48.40K | Mar 03 - Mar 04 | ||
Feb 28, 2025 | SVP & GENERAL COUNSEL | -814.00 | $172.31 | -$140.26K | SELL | -1.79% | 44.67K | Feb 26 - Feb 27 | ||
Feb 28, 2025 | EVP, REGIONAL BUSINESSES | -1.28K | $172.30 | -$220.38K | SELL | -1.71% | 73.61K | Feb 26 - Feb 27 | ||
Feb 21, 2025 | SVP & GENERAL COUNSEL | -978.00 | $170.50 | -$166.75K | SELL | -2.10% | 45.49K | Feb 19 - Feb 20 | ||
Feb 21, 2025 | SVP FOR DIAGNOSTIC SERVICES | -320.00 | $169.71 | -$54.31K | SELL | -1.74% | 18.08K | Feb 19 | ||
Feb 21, 2025 | EVP, REGIONAL BUSINESSES | -1.43K | $170.51 | -$244.51K | SELL | -1.88% | 74.89K | Feb 19 - Feb 20 | ||
Feb 07, 2025 | DIRECTOR | -1.25K | $164.57 | -$205.71K | SELL | -6.90% | 16.87K | Feb 05 | ||
Feb 07, 2025 | SVP & CHIEF COMMERCIAL OFFICER | -403.00 | $164.30 | -$66.21K | SELL | -8.02% | 4.62K | Feb 05 | ||
Dec 02, 2024 | SVP & GENERAL COUNSEL | 0.00 | $124.85 | -$2.69M | SELL-OPTIONS | 0.00% | 44.10K | Nov 29 | ||
Dec 02, 2024 | EVP, REGIONAL BUSINESSES | 0.00 | $133.28 | -$1.97M | SELL-OPTIONS | 0.00% | 72.80K | Nov 27 | ||
Nov 07, 2024 | SVP, CORP. CONTROLLER & CAO | 0.00 | $111.35 | -$1.60M | SELL-OPTIONS | 0.00% | 35.63K | Nov 06 | ||
Oct 30, 2024 | SVP, CLINICAL SOLUTIONS | -1.77K | $156.92 | -$278.53K | SELL | -13.58% | 11.30K | Oct 28 | ||
Sep 03, 2024 | SVP & GENERAL COUNSEL | 0.00 | $125.38 | -$1.93M | SELL-OPTIONS | 0.00% | 44.07K | Aug 29 | ||
Aug 29, 2024 | SVP, CLINICAL SOLUTIONS | -1.99K | $153.26 | -$304.99K | SELL | -13.26% | 13.02K | Aug 28 | ||
Jul 26, 2024 | SVP & CHIEF COMMERCIAL OFFICER | -414.00 | $145.03 | -$59.21K | SELL | -7.62% | 5.02K | Jul 22 - Jul 24 | ||
May 01, 2024 | SVP, CLINICAL SOLUTIONS | -1.76K | $140.00 | -$246.40K | SELL | -10.51% | 14.99K | Apr 29 | ||
Mar 01, 2024 | EVP, REGIONAL BUSINESSES | -7.95K | $126.44 | -$1.00M | SELL | -9.84% | 72.76K | Feb 28 - Feb 29 | ||
Mar 01, 2024 | SVP & GENERAL COUNSEL | -6.47K | $125.94 | -$815.11K | SELL | -12.82% | 44.02K | Feb 28 - Feb 29 | ||
Feb 23, 2024 | SVP & GENERAL COUNSEL | -1.07K | $125.71 | -$134.26K | SELL | -2.28% | 45.75K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | DIRECTOR | -2.50K | $126.64 | -$316.60K | SELL | -13.28% | 16.33K | Feb 23 | ||
Feb 23, 2024 | EVP, REGIONAL BUSINESSES | -1.31K | $125.72 | -$165.20K | SELL | -1.72% | 75.15K | Feb 21 - Feb 22 | ||
Mar 08, 2023 | SVP & GENERAL COUNSEL | 0.00 | $145.84 | $34.75K | GRANT | 0.00% | 43.94K | Mar 06 - Mar 07 | ||
Mar 08, 2023 | SVP, REGIONAL BUSINESSES | 0.00 | $145.90 | $38.79K | GRANT | 0.00% | 72.06K | Mar 06 - Mar 07 | ||
Mar 06, 2023 | SVP, REGIONAL BUSINESSES | -717.00 | $140.63 | -$100.83K | SELL | -0.99% | 72.06K | Mar 03 | ||
Mar 03, 2023 | SVP & GENERAL COUNSEL | -913.00 | $139.29 | -$127.18K | SELL | -2.04% | 43.94K | Mar 01 - Mar 02 | ||
Feb 27, 2023 | SVP & GENERAL COUNSEL | 216.00 | $143.77 | -$320.02K | GRANT | 0.48% | 44.85K | Feb 23 - Feb 24 | ||
Feb 27, 2023 | SVP, REGIONAL BUSINESSES | 1.19K | $143.76 | -$381.24K | GRANT | 1.65% | 73.17K | Feb 23 - Feb 24 | ||
Dec 05, 2022 | DIRECTOR | 0.00 | $104.94 | -$192.60K | SELL-OPTIONS | 0.00% | 24.15K | Dec 01 | ||
Nov 29, 2022 | SVP, REGIONAL BUSINESSES | 0.00 | $117.90 | -$2.55M | SELL-OPTIONS | 0.00% | 71.96K | Nov 28 | ||
Nov 02, 2022 | DIRECTOR | 0.00 | $102.56 | -$165.98K | SELL-OPTIONS | 0.00% | 24.15K | Nov 01 | ||
Oct 27, 2022 | VP, CORP. CONTROLLER & CAO | 0.00 | $99.40 | -$1.41M | SELL-OPTIONS | 0.00% | 32.67K | Oct 26 | ||
Oct 04, 2022 | DIRECTOR | 0.00 | $92.31 | -$124.33K | SELL-OPTIONS | 0.00% | 23.93K | Oct 03 | ||
Sep 06, 2022 | DIRECTOR | 0.00 | $93.12 | -$127.59K | SELL-OPTIONS | 0.00% | 23.93K | Sep 01 | ||
Aug 02, 2022 | DIRECTOR | 0.00 | $98.45 | -$150.37K | SELL-OPTIONS | 0.00% | 23.93K | Aug 01 | ||
Jul 05, 2022 | DIRECTOR | 0.00 | $95.46 | -$152.03K | SELL-OPTIONS | 0.00% | 23.93K | Jul 01 | ||
May 26, 2022 | CHAIRMAN, CEO AND PRESIDENT | 0.00 | $117.18 | -$1.18M | SELL-OPTIONS | 0.00% | 334.83K | May 25 | ||
May 25, 2022 | CHAIRMAN, CEO AND PRESIDENT | 0.00 | $117.17 | -$16.53M | SELL-OPTIONS | 0.00% | 334.83K | May 23 - May 24 | ||
May 19, 2022 | SVP & GENERAL COUNSEL | 0.00 | $103.24 | -$3.72M | SELL-OPTIONS | 0.00% | 44.56K | May 17 | ||
Mar 09, 2022 | SVP & GENERAL COUNSEL | 0.00 | $131.47 | -$31.89K | GRANT | 0.00% | 44.53K | Mar 07 - Mar 08 | ||
Mar 09, 2022 | SVP, GROUP EXEC. CLIN. FRAN. | 0.00 | $131.43 | -$36.00K | GRANT | 0.00% | 71.90K | Mar 07 - Mar 08 | ||
Mar 02, 2022 | SVP & GENERAL COUNSEL | -661.00 | $130.00 | -$85.93K | SELL | -1.46% | 44.53K | Feb 28 | ||
Feb 28, 2022 | SVP, GROUP EXEC. CLIN. FRAN. | 578.00 | $126.26 | -$347.21K | GRANT | 0.81% | 71.90K | Feb 24 | ||
Feb 28, 2022 | SVP & GENERAL COUNSEL | 1.07K | $126.26 | -$210.73K | GRANT | 2.43% | 45.19K | Feb 24 | ||
Dec 01, 2021 | SVP, GROUP EXEC. CLIN. FRAN. | 0.00 | $126.30 | -$2.29M | SELL-OPTIONS | 0.00% | 72.86K | Nov 29 | ||
Jul 30, 2021 | CHAIRMAN, CEO AND PRESIDENT | 0.00 | $117.99 | -$6.63M | SELL-OPTIONS | 0.00% | 284.43K | Jul 28 - Jul 29 | ||
Jul 28, 2021 | CHAIRMAN, CEO AND PRESIDENT | 0.00 | $117.90 | -$1.71M | SELL-OPTIONS | 0.00% | 284.43K | Jul 26 - Jul 27 | ||
Jul 28, 2021 | DIRECTOR | 0.00 | $99.35 | -$976.54K | SELL-OPTIONS | 0.00% | 31.22K | Jul 27 | ||
May 11, 2021 | SVP, GROUP EXEC. CLIN. FRAN. | -8.54K | $139.96 | -$1.19M | SELL | -10.49% | 72.83K | May 07 | ||
May 07, 2021 | SVP & GENERAL COUNSEL | 0.00 | $104.09 | -$2.96M | SELL-OPTIONS | 0.00% | 45.38K | May 05 | ||
Mar 11, 2021 | SVP & GENERAL COUNSEL | 0.00 | $116.86 | -$28.15K | GRANT | 0.00% | 45.36K | Mar 09 - Mar 10 | ||
Mar 01, 2021 | SVP & GENERAL COUNSEL | -801.00 | $115.49 | -$92.51K | SELL | -1.73% | 45.37K | Feb 25 | ||
Feb 25, 2021 | SVP & GENERAL COUNSEL | -2.34K | $119.02 | -$278.04K | SELL | -4.82% | 46.17K | Feb 23 - Feb 24 | ||
Dec 28, 2020 | — | 0.00 | $93.44 | -$4.40M | OPTION EXERCISE | 0.00% | 73.58K | Dec 24 | ||
Nov 27, 2020 | — | 0.00 | $91.84 | -$417.73K | OPTION EXERCISE | 0.00% | 29.86K | Nov 24 | ||
Nov 24, 2020 | — | -11.22K | $126.30 | -$1.42M | SELL | -28.36% | 28.35K | Nov 23 | ||
Oct 23, 2020 | — | 0.00 | $91.12 | -$708.01K | OPTION EXERCISE | 0.00% | 25.73K | Oct 21 | ||
Oct 19, 2020 | — | 0.00 | $93.25 | -$15.62M | OPTION EXERCISE | 0.00% | 237.75K | Oct 16 | ||
Oct 15, 2020 | — | 0.00 | $85.58 | -$2.38M | OPTION EXERCISE | 0.00% | 45.26K | Oct 14 | ||
Sep 04, 2020 | — | 0.00 | $88.56 | -$2.57M | OPTION EXERCISE | 0.00% | 72.47K | Sep 02 | ||
Jun 10, 2020 | — | 0.00 | $94.20 | -$3.34M | OPTION EXERCISE | 0.00% | 73.58K | Jun 08 | ||
Jun 10, 2020 | — | 0.00 | $87.55 | -$681.51K | OPTION EXERCISE | 0.00% | 20.50K | Jun 08 | ||
Apr 28, 2020 | — | 0.00 | $91.59 | -$478.53K | OPTION EXERCISE | 0.00% | 237.75K | Apr 27 | ||
Apr 28, 2020 | — | -5.00K | $111.02 | -$555.08K | SELL | -18.25% | 22.39K | Apr 27 | ||
Mar 17, 2020 | — | -3.51K | $87.75 | -$308.25K | SELL | -8.44% | 38.09K | Mar 16 | ||
Mar 12, 2020 | — | 0.00 | $105.91 | $4.81K | GRANT OR AWARD | 0.00% | 45.20K | Mar 10 - Mar 11 | ||
Mar 12, 2020 | — | 0.00 | $105.91 | $5.53K | GRANT OR AWARD | 0.00% | 72.41K | Mar 10 - Mar 11 | ||
Mar 12, 2020 | — | 11.19K | $106.41 | $1.19M | GRANT OR AWARD | 4.94% | 237.75K | Mar 10 | ||
Mar 10, 2020 | — | 0.00 | $91.92 | -$9.55M | OPTION EXERCISE | 0.00% | 226.56K | Mar 06 | ||
Feb 28, 2020 | — | -1.68K | $110.96 | -$186.30K | TAX | -3.58% | 45.19K | Feb 26 - Feb 27 | ||
Feb 28, 2020 | — | -1.93K | $110.97 | -$214.62K | TAX | -2.60% | 72.42K | Feb 26 - Feb 27 | ||
Feb 28, 2020 | — | -2.80K | $111.04 | -$310.59K | TAX | -6.84% | 38.10K | Feb 26 - Feb 27 | ||
Feb 26, 2020 | — | -1.79K | $112.72 | -$202.10K | TAX | -4.20% | 40.90K | Feb 24 - Feb 25 | ||
Feb 26, 2020 | — | -1.19K | $112.71 | -$134.46K | TAX | -1.58% | 74.34K | Feb 24 - Feb 25 | ||
Jan 03, 2020 | — | 9.00 | $87.11 | -$5.30M | OPTION EXERCISE | 0.02% | 36.54K | Jan 02 | ||
Dec 04, 2019 | SVP & GENERAL COUNSEL | 0.00 | $81.25 | -$2.33M | SELL-OPTIONS | 0.00% | 44.54K | Nov 27 | ||
Nov 27, 2019 | DIRECTOR | 0.00 | $81.46 | -$411.27K | SELL-OPTIONS | 0.00% | 28.33K | Nov 26 | ||
Sep 19, 2019 | VP, CORP. CONTROLLER & CAO | 0.00 | $80.83 | -$251.75K | SELL-OPTIONS | 0.00% | 24.35K | Sep 17 | ||
Jun 17, 2019 | CHAIRMAN, PRESIDENT AND CEO | 0.00 | $76.08 | -$11.70M | SELL-OPTIONS | 0.00% | 213.05K | Jun 13 | ||
Jun 17, 2019 | EXECUTIVE VICE PRESIDENT & CFO | 0.00 | $76.08 | -$3.49M | SELL-OPTIONS | 0.00% | 66.02K | Jun 13 | ||
Apr 26, 2019 | EVP, GENERAL DIAGNOSTICS | 0.00 | $77.84 | -$1.63M | SELL-OPTIONS | 0.00% | 36.53K | Apr 24 | ||
Apr 10, 2019 | EVP, GENERAL DIAGNOSTICS | -8.00K | $90.29 | -$722.33K | SELL | -17.96% | 36.53K | Apr 08 | ||
Apr 08, 2019 | SVP, GROUP EXEC. CLIN. FRAN. | -5.89K | $80.88 | -$1.71M | SELL | -7.62% | 71.45K | Apr 04 | ||
Mar 05, 2019 | SVP & GENERAL COUNSEL | 0.00 | $86.85 | $168.65 | GRANT | 0.00% | 44.47K | Mar 01 - Mar 04 | ||
Mar 05, 2019 | SVP, COMMERCIAL | 0.00 | $86.85 | $194.60 | GRANT | 0.00% | 39.03K | Mar 01 - Mar 04 | ||
Feb 28, 2019 | SVP & GENERAL COUNSEL | -2.32K | $87.12 | -$202.02K | SELL | -4.96% | 44.46K | Feb 26 - Feb 27 | ||
Feb 28, 2019 | SVP, COMMERCIAL | -2.61K | $87.15 | -$227.29K | SELL | -6.28% | 38.92K | Feb 26 - Feb 27 | ||
Feb 27, 2019 | SVP & GENERAL COUNSEL | -651.00 | $88.23 | -$57.44K | SELL | -1.37% | 46.78K | Feb 25 | ||
Feb 27, 2019 | SVP, COMMERCIAL | -757.00 | $88.24 | -$66.79K | SELL | -1.79% | 41.53K | Feb 25 | ||
Feb 25, 2019 | DIRECTOR | 0.00 | $69.66 | -$289.82K | SELL-OPTIONS | 0.00% | 26.60K | Feb 22 | ||
Jul 12, 2018 | SVP & GENERAL COUNSEL | 0.00 | $85.33 | -$1.71M | SELL-OPTIONS | 0.00% | 44.71K | Jul 10 | ||
Jul 12, 2018 | SVP, COMMERCIAL | 0.00 | $91.59 | -$1.65M | SELL-OPTIONS | 0.00% | 38.88K | Jul 10 | ||
Jul 05, 2018 | SVP, COMMERCIAL | -7.85K | $85.55 | -$3.77M | SELL | -16.79% | 38.88K | Jul 02 | ||
May 30, 2018 | DIRECTOR | -1.64K | $105.61 | -$173.62K | SELL | -21.51% | 6.00K | May 29 | ||
May 29, 2018 | CHAIRMAN, PRESIDENT AND CEO | 0.00 | $81.56 | -$8.57M | SELL-OPTIONS | 0.00% | 191.07K | May 25 | ||
May 29, 2018 | EXECUTIVE VICE PRESIDENT & CFO | 0.00 | $82.04 | -$2.91M | SELL-OPTIONS | 0.00% | 58.20K | May 25 | ||
Mar 12, 2018 | SVP & GROUP EXEC. DIAG. SOL. | -44.74K | $85.35 | -$6.13M | SELL | -58.49% | 31.76K | Mar 08 | ||
Mar 06, 2018 | SVP & GENERAL COUNSEL | 0.00 | $101.00 | $0.00 | GRANT | 0.00% | 44.67K | Mar 02 - Mar 05 | ||
Mar 06, 2018 | EVP, GENERAL DIAGNOSTICS | 0.00 | $101.00 | $0.00 | GRANT | 0.00% | 37.07K | Mar 02 - Mar 05 | ||
Mar 06, 2018 | SVP, GROUP EXEC. CLIN. FRAN. | 0.00 | $101.00 | $0.00 | GRANT | 0.00% | 71.78K | Mar 02 - Mar 05 | ||
Mar 01, 2018 | SVP & GENERAL COUNSEL | -1.91K | $103.66 | -$197.47K | SELL | -4.09% | 44.66K | Feb 27 - Feb 28 | ||
Mar 01, 2018 | SVP, GROUP EXEC. CLIN. FRAN. | -2.38K | $103.69 | -$246.37K | SELL | -3.20% | 71.78K | Feb 27 - Feb 28 | ||
Mar 01, 2018 | EVP, GENERAL DIAGNOSTICS | -2.65K | $103.46 | -$274.57K | SELL | -6.69% | 37.02K | Feb 27 - Feb 28 | ||
Feb 27, 2018 | VP, CORPORATE CONTROLLER | -1.28K | $103.49 | -$132.16K | SELL | -24.65% | 3.90K | Feb 23 - Feb 26 | ||
Feb 27, 2018 | SVP, GROUP EXEC. CLIN. FRAN. | -2.00K | $101.93 | -$203.36K | SELL | -2.62% | 74.15K | Feb 23 - Feb 26 | ||
Feb 27, 2018 | EVP, GENERAL DIAGNOSTICS | -2.67K | $101.98 | -$272.09K | SELL | -6.30% | 39.68K | Feb 23 - Feb 26 | ||
Jan 31, 2018 | CHAIRMAN, PRESIDENT AND CEO | 0.00 | $82.59 | -$5.22M | SELL-OPTIONS | 0.00% | 166.12K | Jan 29 | ||
Jan 26, 2018 | SVP, GROUP EXEC. CLIN. FRAN. | 0.00 | $78.08 | -$1.10M | SELL-OPTIONS | 0.00% | 73.25K | Jan 24 | ||
Jan 04, 2018 | EVP, GENERAL DIAGNOSTICS | 0.00 | $75.42 | -$2.97M | SELL-OPTIONS | 0.00% | 38.05K | Jan 02 | ||
Sep 13, 2017 | DIRECTOR | 0.00 | $82.61 | -$2.08M | SELL-OPTIONS | 0.00% | 34.67K | Sep 11 | ||
Sep 13, 2017 | CHAIRMAN, PRESIDENT AND CEO | 0.00 | $83.17 | -$2.96M | SELL-OPTIONS | 0.00% | 166.12K | Sep 11 - Sep 12 | ||
Sep 07, 2017 | DIRECTOR | 0.00 | $82.58 | -$193.46K | SELL-OPTIONS | 0.00% | 34.67K | Sep 05 | ||
Sep 07, 2017 | CHAIRMAN, PRESIDENT AND CEO | 0.00 | $83.10 | -$125.88K | SELL-OPTIONS | 0.00% | 166.12K | Sep 05 | ||
Aug 08, 2017 | DIRECTOR | -296.00 | $106.66 | -$31.57K | SELL | -4.70% | 6.00K | Aug 04 | ||
Jul 31, 2017 | DIRECTOR | -1.30K | $108.73 | -$141.78K | SELL | -17.16% | 6.30K | Jul 27 | ||
Jun 21, 2017 | SVP & GROUP EXEC. DIAG. SOL. | 0.00 | $80.75 | -$5.73M | SELL-OPTIONS | 0.00% | 73.18K | Jun 19 | ||
Jun 21, 2017 | SVP, GROUP EXEC. CLIN. FRAN. | 0.00 | $82.47 | -$3.00M | SELL-OPTIONS | 0.00% | 73.19K | Jun 19 | ||
Apr 26, 2017 | DIRECTOR | 0.00 | $80.85 | -$283.31K | SELL-OPTIONS | 0.00% | 19.90K | Apr 24 | ||
Apr 24, 2017 | SVP & GENERAL COUNSEL | 0.00 | $78.39 | -$1.28M | SELL-OPTIONS | 0.00% | 45.12K | Apr 20 | ||
Mar 20, 2017 | SVP & GENERAL COUNSEL | 0.00 | $77.82 | -$620.32K | SELL-OPTIONS | 0.00% | 45.13K | Mar 16 | ||
Mar 06, 2017 | SVP & GENERAL COUNSEL | -4.48K | $98.29 | -$440.14K | SELL | -9.03% | 45.13K | Mar 03 | ||
Mar 06, 2017 | SVP, GROUP EXEC. CLIN. FRAN. | -1.13K | $98.16 | -$112.44K | SELL | -1.43% | 77.92K | Mar 02 - Mar 03 | ||
Mar 03, 2017 | SVP & GENERAL COUNSEL | 4.01K | $98.10 | $393.43K | GRANT | 8.79% | 49.61K | Mar 01 - Mar 02 | ||
Feb 28, 2017 | SVP & GENERAL COUNSEL | -914.00 | $96.50 | -$88.20K | SELL | -1.94% | 46.10K | Feb 24 - Feb 27 | ||
Feb 24, 2017 | DIRECTOR | -2.00K | $95.51 | -$191.02K | SELL | -10.78% | 16.56K | Feb 22 | ||
Feb 17, 2017 | SVP, CLIN. FRANCHISE SOLUTIONS | -1.61K | $94.65 | -$152.86K | SELL | -2.05% | 77.15K | Feb 15 | ||
Feb 15, 2017 | SVP & GENERAL COUNSEL | -2.49K | $93.81 | -$233.86K | SELL | -5.33% | 44.30K | Feb 13 | ||
Feb 06, 2017 | SVP & GENERAL COUNSEL | 0.00 | $72.54 | -$1.79M | SELL-OPTIONS | 0.00% | 46.80K | Feb 02 | ||
Feb 01, 2017 | SVP, CLIN. FRANCHISE SOLUTIONS | 0.00 | $72.30 | -$2.93M | SELL-OPTIONS | 0.00% | 77.03K | Jan 30 | ||
Nov 17, 2016 | DIRECTOR | -8.31K | $70.75 | -$1.69M | SELL | -37.76% | 13.70K | Nov 15 | ||
Aug 22, 2016 | DIRECTOR | 0.00 | $70.26 | -$116.01K | SELL-OPTIONS | 0.00% | 19.89K | Aug 19 | ||
Aug 11, 2016 | DIRECTOR | 0.00 | $70.48 | -$117.77K | SELL-OPTIONS | 0.00% | 19.89K | Aug 10 | ||
Aug 04, 2016 | DIRECTOR | 296.00 | $77.57 | -$81.57K | SELL-OPTIONS | 5.16% | 6.03K | Aug 03 | ||
Jul 27, 2016 | DIRECTOR | -1.00K | $84.36 | -$84.36K | SELL | -5.11% | 18.56K | Jul 25 | ||
Jun 01, 2016 | SVP, CLIN. FRANCHISE SOLUTIONS | 0.00 | $66.75 | -$995.48K | SELL-OPTIONS | 0.00% | 80.45K | May 27 | ||
May 16, 2016 | DIRECTOR | 0.00 | $63.62 | -$193.06K | SELL-OPTIONS | 0.00% | 17.68K | May 12 | ||
May 11, 2016 | SVP, COMMERCIAL | 0.00 | $67.96 | -$934.72K | SELL-OPTIONS | 0.00% | 32.33K | May 09 | ||
May 09, 2016 | SVP, COMMERCIAL | 0.00 | $65.42 | -$1.07M | SELL-OPTIONS | 0.00% | 32.33K | May 06 | ||
Apr 27, 2016 | SVP, CLIN. FRANCHISE SOLUTIONS | -5.88K | $62.82 | -$988.17K | SELL | -6.78% | 80.89K | Apr 25 | ||
Mar 03, 2016 | SVP & GENERAL COUNSEL | -3.42K | $67.39 | -$233.67K | SELL | -6.84% | 46.68K | Mar 01 | ||
Aug 13, 2015 | DIRECTOR | -2.27K | $72.00 | -$163.15K | SELL | -14.89% | 12.95K | Aug 12 | ||
Aug 10, 2015 | DIRECTOR | -2.20K | $74.35 | -$163.57K | SELL | -11.48% | 16.96K | Aug 06 | ||
Mar 03, 2015 | SVP & GENERAL COUNSEL | -4.56K | $71.04 | -$337.35K | SELL | -8.90% | 46.68K | Feb 27 - Mar 03 | ||
Feb 18, 2015 | SVP & GENERAL COUNSEL | -488.00 | $71.41 | -$34.85K | SELL | -1.02% | 47.58K | Feb 17 | ||
Feb 18, 2015 | SENIOR VICE PRESIDENT & CFO | -1.00K | $71.51 | -$71.65K | SELL | -2.43% | 40.24K | Feb 17 | ||
Feb 12, 2015 | DIRECTOR | 0.00 | $60.45 | -$168.24K | SELL-OPTIONS | 0.00% | 26.34K | Feb 11 | ||
Feb 05, 2015 | DIRECTOR | 0.00 | $61.19 | -$179.95K | SELL-OPTIONS | 0.00% | 16.85K | Feb 04 | ||
Feb 05, 2015 | DIRECTOR | 0.00 | $61.14 | -$179.17K | SELL-OPTIONS | 0.00% | 18.85K | Feb 04 | ||
Feb 04, 2015 | DIRECTOR | 0.00 | $61.71 | -$162.64K | SELL-OPTIONS | 0.00% | 16.82K | Feb 03 | ||
Feb 04, 2015 | VP AND CORPORATE CONTROLLER | -3.00K | $71.50 | -$214.50K | SELL | -16.09% | 15.64K | Feb 02 | ||
Nov 20, 2014 | VP AND CORPORATE CONTROLLER | 0.00 | $55.75 | -$165.10K | SELL-OPTIONS | 0.00% | 18.53K | Nov 18 | ||
Nov 18, 2014 | SVP AND CHIEF MEDICAL OFFICER | 0.00 | $59.25 | -$1.24M | SELL-OPTIONS | 0.00% | 59.71K | Nov 14 - Nov 17 | ||
Nov 12, 2014 | DIRECTOR | 0.00 | $54.86 | -$136.68K | SELL-OPTIONS | 0.00% | 16.85K | Nov 10 | ||
Nov 05, 2014 | SVP, PHYSICIAN SERVICES BUS. | 0.00 | $54.84 | -$347.96K | SELL-OPTIONS | 0.00% | 79.78K | Nov 03 | ||
Aug 11, 2014 | SVP, CLINICAL FRANCHISES | 0.00 | $56.65 | -$173.15K | SELL-OPTIONS | 0.00% | 79.75K | Aug 08 | ||
Aug 05, 2014 | SVP & GENERAL COUNSEL | 0.00 | $54.25 | -$194.42K | SELL-OPTIONS | 0.00% | 47.90K | Aug 04 | ||
Jul 31, 2014 | SVP & GENERAL COUNSEL | 0.00 | $55.00 | -$246.03K | SELL-OPTIONS | 0.00% | 47.89K | Jul 30 | ||
Jul 31, 2014 | DIRECTOR | 0.00 | $56.16 | -$99.44K | SELL-OPTIONS | 0.00% | 15.15K | Jul 30 | ||
Jul 29, 2014 | DIRECTOR | 0.00 | $59.03 | -$52.40K | SELL-OPTIONS | 0.00% | 12.88K | Jul 29 | ||
Jul 29, 2014 | VP AND CORPORATE CONTROLLER | 0.00 | $57.45 | -$34.11K | SELL-OPTIONS | 0.00% | 18.32K | Jul 28 | ||
Jul 28, 2014 | DIRECTOR | 0.00 | $55.92 | -$95.68K | SELL-OPTIONS | 0.00% | 16.82K | Jul 24 - Jul 25 | ||
May 22, 2014 | DIRECTOR | 949.00 | $52.80 | -$123.56K | SELL-OPTIONS | 5.98% | 16.82K | May 21 - May 22 | ||
May 09, 2014 | DIRECTOR | 0.00 | $52.50 | -$69.11K | SELL-OPTIONS | 0.00% | 13.93K | May 07 | ||
May 07, 2014 | SENIOR VICE PRESIDENT & CFO | 4.00K | $55.51 | $222.02K | BUY | 9.94% | 44.22K | May 05 | ||
May 02, 2014 | DIRECTOR | 0.00 | $50.25 | -$329.47K | SELL-OPTIONS | 0.00% | 22.15K | Apr 30 | ||
Mar 05, 2014 | SVP & GENERAL COUNSEL | -778.00 | $53.00 | -$41.23K | SELL | -1.60% | 47.74K | Mar 04 | ||
Feb 28, 2014 | DIRECTOR | 0.00 | $50.89 | -$36.99K | SELL-OPTIONS | 0.00% | 12.23K | Feb 27 | ||
Feb 27, 2014 | SVP & GENERAL COUNSEL | -1.32K | $53.12 | -$70.02K | SELL | -2.62% | 48.97K | Feb 26 - Feb 27 | ||
Feb 20, 2014 | SVP & GENERAL COUNSEL | -2.86K | $52.26 | -$149.47K | SELL | -5.38% | 50.29K | Feb 19 | ||
Feb 19, 2014 | DIRECTOR | 0.00 | $48.85 | -$245.14K | SELL-OPTIONS | 0.00% | 15.93K | Feb 18 | ||
Feb 14, 2014 | DIRECTOR | 0.00 | $48.46 | -$221.55K | SELL-OPTIONS | 0.00% | 26.23K | Feb 12 | ||
Feb 07, 2014 | DIRECTOR | 5.00K | $50.71 | $253.53K | BUY | 759.88% | 5.66K | Feb 06 | ||
Nov 13, 2013 | SVP & GENERAL COUNSEL | 0.00 | $55.75 | -$400.58K | SELL-OPTIONS | 0.00% | 49.80K | Nov 11 | ||
Nov 05, 2013 | VP AND CORPORATE CONTROLLER | 0.00 | $57.37 | -$170.74K | SELL-OPTIONS | 0.00% | 17.28K | Nov 04 - Nov 05 | ||
Nov 05, 2013 | DIRECTOR | -658.00 | $63.00 | -$41.45K | SELL | -6.20% | 9.95K | Nov 05 | ||
Nov 04, 2013 | DIRECTOR | 0.00 | $55.63 | -$65.20K | SELL-OPTIONS | 0.00% | 10.61K | Oct 31 | ||
Oct 30, 2013 | VP AND CORPORATE CONTROLLER | 0.00 | $49.71 | -$111.44K | SELL-OPTIONS | 0.00% | 17.25K | Oct 29 | ||
Oct 25, 2013 | DIRECTOR | -2.00K | $58.10 | -$116.20K | SELL | -12.56% | 13.93K | Oct 25 | ||
Sep 18, 2013 | SVP, CLINICAL FRANCHISES | 0.00 | $57.12 | -$422.72K | SELL-OPTIONS | 0.00% | 75.80K | Sep 16 - Sep 17 | ||
Aug 15, 2013 | SVP, CLINICAL FRANCHISES | 0.00 | $50.14 | -$641.02K | SELL-OPTIONS | 0.00% | 75.79K | Aug 14 | ||
Aug 12, 2013 | DIRECTOR | -1.95K | $59.45 | -$116.11K | SELL | -10.95% | 15.88K | Aug 12 | ||
Aug 12, 2013 | VP AND CORPORATE CONTROLLER | 1.14K | $49.88 | -$159.46K | SELL-OPTIONS | 7.09% | 17.15K | Aug 08 | ||
Jul 25, 2013 | DIRECTOR | -4.20K | $58.99 | -$247.77K | SELL | -25.57% | 12.23K | Jul 23 | ||
Jun 19, 2013 | SVP & GENERAL COUNSEL | 0.00 | $54.08 | -$2.17M | SELL-OPTIONS | 0.00% | 49.64K | Jun 17 - Jun 18 | ||
May 23, 2013 | DIRECTOR | 1.98K | $53.35 | -$542.68K | SELL-OPTIONS | 12.46% | 17.83K | May 21 - May 22 | ||
May 15, 2013 | DIRECTOR | -1.21K | $59.41 | -$72.12K | SELL | -12.33% | 8.63K | May 14 | ||
May 03, 2013 | DIRECTOR | 0.00 | $56.30 | -$18.01K | SELL-OPTIONS | 0.00% | 13.95K | May 02 | ||
Apr 12, 2013 | DIRECTOR | 0.00 | $48.42 | -$29.18K | SELL-OPTIONS | 0.00% | 15.85K | Apr 11 | ||
Mar 07, 2013 | SVP & GENERAL COUNSEL | 0.00 | $56.42 | -$179.12K | GRANT | 0.00% | 49.56K | Mar 05 - Mar 06 | ||
Mar 06, 2013 | SVP & GENERAL COUNSEL | -1.24K | $56.39 | -$69.98K | SELL | -2.44% | 49.56K | Mar 04 - Mar 06 | ||
Feb 22, 2013 | DIRECTOR | -2.00K | $57.42 | -$114.84K | SELL | -11.20% | 15.85K | Feb 20 | ||
Feb 22, 2013 | DIRECTOR | 0.00 | $56.35 | -$18.96K | SELL-OPTIONS | 0.00% | 14.45K | Feb 20 | ||
Feb 19, 2013 | SVP & GENERAL COUNSEL | -2.30K | $57.32 | -$131.78K | SELL | -4.81% | 45.52K | Feb 15 - Feb 19 | ||
Feb 12, 2013 | SVP & GENERAL COUNSEL | -4.84K | $57.75 | -$279.45K | SELL | -9.19% | 47.81K | Feb 10 - Feb 12 | ||
Jan 18, 2013 | DIRECTOR | 0.00 | $57.70 | -$46.00K | SELL-OPTIONS | 0.00% | 13.95K | Jan 17 | ||
Oct 05, 2012 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $52.21 | -$1.10M | SELL-OPTIONS | 0.00% | 156.38K | Oct 03 | ||
Sep 07, 2012 | DIRECTOR | 0.00 | $58.86 | -$69.19K | SELL-OPTIONS | 0.00% | 17.85K | Sep 06 | ||
Aug 16, 2012 | DIRECTOR | 0.00 | $44.85 | -$575.62K | SELL-OPTIONS | 0.00% | 13.95K | Aug 15 | ||
Aug 14, 2012 | DIRECTOR | 0.00 | $49.04 | -$616.06K | SELL-OPTIONS | 0.00% | 24.25K | Aug 10 | ||
Aug 09, 2012 | SVP, PHYSICIAN SERVICES | 0.00 | $56.17 | -$314.92K | SELL-OPTIONS | 0.00% | 69.46K | Aug 08 | ||
Aug 09, 2012 | DIRECTOR | -1.77K | $57.70 | -$152.16K | SELL | -15.23% | 9.85K | Aug 08 | ||
Aug 07, 2012 | PRESIDENT AND CEO | 5.00K | $59.34 | $296.68K | BUY | 7.93% | 68.03K | Aug 07 | ||
Aug 06, 2012 | DIRECTOR | -2.80K | $59.26 | -$165.92K | SELL | -13.56% | 17.85K | Aug 03 | ||
Aug 02, 2012 | SVP & GENERAL COUNSEL | 11.41K | $47.64 | -$2.12M | SELL-OPTIONS | 27.76% | 52.50K | Jul 31 - Aug 01 | ||
Jul 13, 2012 | DIRECTOR | 0.00 | $50.39 | -$696.90K | SELL-OPTIONS | 0.00% | 20.18K | Jul 12 | ||
Jul 03, 2012 | VP AND CORPORATE CONTROLLER | 0.00 | $55.89 | -$109.58K | SELL-OPTIONS | 0.00% | 13.98K | Jun 29 | ||
Jul 03, 2012 | DIRECTOR | 0.00 | $45.56 | -$42.16K | SELL-OPTIONS | 0.00% | 20.65K | Jun 29 | ||
Jul 02, 2012 | DIRECTOR | 0.00 | $44.73 | -$570.90K | SELL-OPTIONS | 0.00% | 20.65K | Jun 28 | ||
May 31, 2012 | DIRECTOR | 0.00 | $43.79 | -$24.77K | SELL-OPTIONS | 0.00% | 20.65K | May 30 | ||
May 09, 2012 | PRESIDENT AND CEO | 20.00K | $56.89 | $1.14M | BUY | 46.47% | 63.03K | May 08 | ||
May 09, 2012 | VP AND CORPORATE CONTROLLER | -1.00 | $56.83 | -$56.83 | SELL | -0.03% | 3.01K | May 08 | ||
May 03, 2012 | VP AND CORPORATE CONTROLLER | -2.31K | $58.43 | -$134.69K | SELL | -43.40% | 3.01K | May 01 | ||
May 03, 2012 | DIRECTOR | 0.00 | $55.79 | -$50.37K | SELL-OPTIONS | 0.00% | 11.98K | May 02 | ||
May 03, 2012 | DIRECTOR | -2.33K | $53.72 | -$194.69K | SELL | -19.49% | 9.64K | May 01 | ||
Apr 03, 2012 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $51.21 | -$1.01M | SELL-OPTIONS | 0.00% | 156.34K | Apr 02 | ||
Mar 02, 2012 | SVP & GENERAL COUNSEL | 0.00 | $57.70 | -$653.43K | GRANT | 0.00% | 40.99K | Feb 29 - Mar 01 | ||
Feb 27, 2012 | SVP-ONCOLOGY & NEUROLOGY SRVCS | 0.00 | $57.03 | -$13.19K | SELL-OPTIONS | 0.00% | 74.42K | Feb 24 | ||
Feb 22, 2012 | VP AND CORPORATE CONTROLLER | 0.00 | $57.19 | -$4.43K | SELL-OPTIONS | 0.00% | 16.37K | Feb 21 | ||
Feb 17, 2012 | SVP & GENERAL COUNSEL | -1.46K | $57.38 | -$83.89K | SELL | -3.90% | 36.03K | Feb 16 | ||
Feb 16, 2012 | SVP & GENERAL COUNSEL | -5.38K | $57.31 | -$308.31K | SELL | -12.55% | 37.49K | Feb 14 - Feb 15 | ||
Feb 07, 2012 | SVP-ONCOLOGY & NEUROLOGY SRVCS | 0.00 | $57.08 | -$38.00K | SELL-OPTIONS | 0.00% | 78.91K | Feb 03 | ||
Feb 01, 2012 | CHAIRMAN, PRESIDENT & CEO | -90.00K | $53.48 | -$5.43M | SELL | -25.16% | 267.75K | Jan 30 - Feb 01 | ||
Jan 30, 2012 | DIRECTOR | 0.00 | $54.16 | -$285.89K | SELL-OPTIONS | 0.00% | 11.98K | Jan 27 | ||
Jan 30, 2012 | DIRECTOR | 0.00 | $54.20 | -$288.03K | SELL-OPTIONS | 0.00% | 18.20K | Jan 27 | ||
Jan 30, 2012 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $55.69 | -$784.27K | SELL-OPTIONS | 0.00% | 141.45K | Jan 26 | ||
Jan 30, 2012 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $49.76 | -$6.35M | SELL-OPTIONS | 0.00% | 357.75K | Jan 26 - Jan 27 | ||
Jan 30, 2012 | DIRECTOR | 0.00 | $56.13 | -$57.33K | SELL-OPTIONS | 0.00% | 11.98K | Jan 26 | ||
Jan 30, 2012 | DIRECTOR | 0.00 | $54.11 | -$282.80K | SELL-OPTIONS | 0.00% | 22.27K | Jan 26 | ||
Jan 04, 2012 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $53.70 | -$203.96K | SELL-OPTIONS | 0.00% | 357.45K | Jan 03 | ||
Dec 22, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $50.62 | -$59.19K | SELL-OPTIONS | 0.00% | 141.44K | Dec 21 | ||
Dec 02, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $53.34 | -$189.29K | SELL-OPTIONS | 0.00% | 357.45K | Dec 01 | ||
Dec 02, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $50.82 | -$60.84K | SELL-OPTIONS | 0.00% | 141.44K | Dec 01 | ||
Nov 22, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $48.94 | -$45.28K | SELL-OPTIONS | 0.00% | 141.44K | Nov 21 | ||
Nov 10, 2011 | VP AND CORPORATE CONTROLLER | 0.00 | $53.12 | -$116.81K | SELL-OPTIONS | 0.00% | 17.46K | Nov 08 | ||
Nov 03, 2011 | DIRECTOR | 0.00 | $51.58 | -$61.88K | SELL-OPTIONS | 0.00% | 12.48K | Nov 03 | ||
Nov 03, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $51.71 | -$122.24K | SELL-OPTIONS | 0.00% | 357.45K | Nov 01 | ||
Nov 03, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $49.14 | -$46.94K | SELL-OPTIONS | 0.00% | 141.44K | Nov 01 | ||
Nov 01, 2011 | DIRECTOR | 0.00 | $55.13 | -$55.89K | SELL-OPTIONS | 0.00% | 18.68K | Oct 28 | ||
Nov 01, 2011 | SVP-ONCOLOGY & NEUROLOGY SRVCS | 0.00 | $54.87 | -$101.40K | SELL-OPTIONS | 0.00% | 78.78K | Oct 28 | ||
Nov 01, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $41.09 | -$1.63M | SELL-OPTIONS | 0.00% | 357.45K | Oct 28 | ||
Oct 31, 2011 | SVP & GENERAL COUNSEL | 0.00 | $48.84 | -$1.82M | SELL-OPTIONS | 0.00% | 45.39K | Oct 27 | ||
Oct 27, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $52.62 | -$372.36K | SELL-OPTIONS | 0.00% | 357.45K | Oct 25 | ||
Oct 25, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $46.39 | -$24.07K | SELL-OPTIONS | 0.00% | 141.43K | Oct 21 | ||
Oct 05, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $46.36 | -$23.84K | SELL-OPTIONS | 0.00% | 141.43K | Oct 03 | ||
Sep 23, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $46.50 | -$24.99K | SELL-OPTIONS | 0.00% | 141.43K | Sep 21 | ||
Sep 06, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $46.73 | -$26.93K | SELL-OPTIONS | 0.00% | 141.43K | Sep 01 | ||
Aug 31, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $46.24 | -$22.87K | SELL-OPTIONS | 0.00% | 141.43K | Aug 29 | ||
Aug 18, 2011 | VP AND CORPORATE CONTROLLER | -1.50K | $49.29 | -$73.94K | SELL | -7.96% | 17.33K | Aug 17 | ||
Aug 03, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $51.43 | -$73.25K | SELL-OPTIONS | 0.00% | 362.45K | Aug 01 | ||
Aug 03, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $48.88 | -$44.74K | SELL-OPTIONS | 0.00% | 141.43K | Aug 01 | ||
Jul 25, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $50.34 | -$56.83K | SELL-OPTIONS | 0.00% | 141.41K | Jul 21 | ||
Jul 05, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $53.85 | -$210.10K | SELL-OPTIONS | 0.00% | 362.24K | Jul 01 | ||
Jul 05, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $51.23 | -$64.27K | SELL-OPTIONS | 0.00% | 141.41K | Jul 01 | ||
Jun 22, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $52.08 | -$71.33K | SELL-OPTIONS | 0.00% | 141.41K | Jun 21 | ||
Jun 20, 2011 | VICE PRESIDENT, OPERATIONS | 0.00 | $54.37 | -$180.16K | SELL-OPTIONS | 0.00% | 47.75K | Jun 16 | ||
Jun 20, 2011 | SVP-ONCOLOGY & NEUROLOGY SRVCS | -3.81K | $60.20 | -$229.66K | SELL | -4.63% | 78.62K | Jun 16 | ||
Jun 16, 2011 | SVP-ONCOLOGY & NEUROLOGY SRVCS | -4.67K | $59.70 | -$278.68K | SELL | -5.36% | 82.44K | Jun 14 | ||
Jun 14, 2011 | SVP-ONCOLOGY & NEUROLOGY SRVCS | -10.62K | $59.20 | -$628.41K | SELL | -10.86% | 87.11K | Jun 13 | ||
Jun 03, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $50.79 | -$60.62K | SELL-OPTIONS | 0.00% | 141.41K | Jun 01 | ||
Jun 02, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $53.40 | -$191.66K | SELL-OPTIONS | 0.00% | 362.24K | Jun 01 | ||
May 25, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $50.47 | -$57.98K | SELL-OPTIONS | 0.00% | 141.41K | May 23 | ||
May 19, 2011 | SVP-ONCOLOGY & NEUROLOGY SRVCS | -1.81K | $52.79 | -$328.69K | SELL | -63.52% | 1.04K | May 17 - May 18 | ||
May 16, 2011 | SVP-PATHOLOGY & HOSP. SERVICES | -1.81K | $52.45 | -$506.33K | SELL | -38.84% | 2.85K | May 12 | ||
May 13, 2011 | VICE PRESIDENT, OPERATIONS | -10.00K | $57.00 | -$570.00K | SELL | -17.33% | 47.71K | May 11 | ||
May 04, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $49.98 | -$53.84K | SELL-OPTIONS | 0.00% | 141.41K | May 02 | ||
May 04, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $52.71 | -$163.29K | SELL-OPTIONS | 0.00% | 362.25K | May 02 | ||
Apr 25, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $50.89 | -$61.39K | SELL-OPTIONS | 0.00% | 141.40K | Apr 21 | ||
Apr 05, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $53.22 | -$184.14K | SELL-OPTIONS | 0.00% | 362.05K | Apr 01 | ||
Apr 05, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $50.64 | -$59.31K | SELL-OPTIONS | 0.00% | 141.40K | Apr 01 | ||
Mar 23, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $48.84 | -$44.43K | SELL-OPTIONS | 0.00% | 141.40K | Mar 21 | ||
Mar 11, 2011 | SVP & GENERAL COUNSEL | -2.60K | $57.50 | -$149.27K | SELL | -5.41% | 45.39K | Mar 09 | ||
Mar 03, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $50.13 | -$55.10K | SELL-OPTIONS | 0.00% | 146.01K | Mar 01 | ||
Mar 03, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $52.75 | -$164.68K | SELL-OPTIONS | 0.00% | 373.14K | Mar 01 | ||
Feb 22, 2011 | SVP & GENERAL COUNSEL | -8.69K | $57.46 | -$499.05K | SELL | -14.74% | 50.22K | Feb 18 | ||
Feb 17, 2011 | SVP-PATHOLOGY & HOSP. SERVICES | 22.87K | $53.02 | -$575.43K | SELL-OPTIONS | 28.21% | 103.96K | Feb 15 - Feb 16 | ||
Feb 16, 2011 | SVP & GENERAL COUNSEL | -20.00K | $57.19 | -$1.14M | SELL | -32.77% | 41.03K | Feb 11 - Feb 15 | ||
Feb 14, 2011 | SVP & GENERAL COUNSEL | -3.30K | $57.19 | -$188.68K | SELL | -5.14% | 60.94K | Feb 10 - Feb 14 | ||
Feb 10, 2011 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $46.53 | -$3.34M | SELL-OPTIONS | 0.00% | 302.21K | Feb 09 | ||
Feb 10, 2011 | DIRECTOR | 0.00 | $51.16 | -$383.98K | SELL-OPTIONS | 0.00% | 10.00K | Feb 09 | ||
Feb 09, 2011 | DIRECTOR | 0.00 | $52.72 | -$247.70K | SELL-OPTIONS | 0.00% | 16.70K | Feb 08 | ||
Feb 09, 2011 | DIRECTOR | 0.00 | $44.05 | -$580.86K | SELL-OPTIONS | 0.00% | 15.23K | Feb 07 | ||
Feb 09, 2011 | DIRECTOR | 0.00 | $44.22 | -$587.80K | SELL-OPTIONS | 0.00% | 16.23K | Feb 07 | ||
Feb 09, 2011 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $49.77 | -$1.82M | SELL-OPTIONS | 0.00% | 116.67K | Feb 07 | ||
Feb 09, 2011 | VP AND CORPORATE CONTROLLER | -5.04K | $44.64 | -$964.13K | SELL | -26.49% | 13.97K | Feb 07 | ||
Feb 02, 2011 | DIRECTOR | -30.76M | $54.96 | -$1.69B | SELL | -100.00% | 0.00 | Jan 31 | ||
May 05, 2010 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $40.91 | -$115.31K | SELL-OPTIONS | 0.00% | 116.63K | May 03 | ||
Apr 05, 2010 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $41.71 | -$121.05K | SELL-OPTIONS | 0.00% | 116.61K | Apr 01 | ||
Mar 03, 2010 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $40.97 | -$115.75K | SELL-OPTIONS | 0.00% | 105.42K | Mar 01 | ||
Feb 23, 2010 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $41.01 | -$4.88M | SELL-OPTIONS | 0.00% | 273.83K | Feb 19 | ||
Feb 22, 2010 | VP AND CORPORATE CONTROLLER | 1.00 | $48.74 | -$170.78K | SELL-OPTIONS | 0.01% | 16.13K | Feb 18 | ||
Feb 05, 2010 | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $40.65 | -$2.38M | SELL-OPTIONS | 0.00% | 87.83K | Feb 03 | ||
Nov 10, 2009 | SVP-PATHOLOGY & HOSP. SERVICES | 0.00 | $47.72 | -$435.03K | SELL-OPTIONS | 0.00% | 63.44K | Nov 06 | ||
Nov 06, 2009 | VICE PRESIDENT, OPERATIONS | 4.23K | $48.67 | -$154.70K | SELL-OPTIONS | 17.36% | 28.61K | Nov 04 | ||
Nov 06, 2009 | SVP-PATHOLOGY & HOSP. SERVICES | 0.00 | $48.69 | -$330.47K | SELL-OPTIONS | 0.00% | 63.44K | Nov 04 | ||
Oct 27, 2009 | VICE PRESIDENT, OPERATIONS | 20.00 | $48.46 | -$798.70 | SELL-OPTIONS | 0.08% | 24.32K | Oct 23 | ||
Oct 27, 2009 | VP AND CORPORATE CONTROLLER | 21.00 | $46.20 | -$240.59K | SELL-OPTIONS | 0.16% | 13.10K | Oct 23 | ||
Aug 24, 2009 | SVP-PATHOLOGY & HOSP. SERVICES | -12.72K | $44.08 | -$1.17M | SELL | -17.77% | 58.86K | Aug 20 - Aug 21 | ||
Aug 18, 2009 | SVP-PATHOLOGY & HOSP. SERVICES | -5.51K | $54.80 | -$302.17K | SELL | -6.76% | 76.05K | Aug 17 | ||
Aug 17, 2009 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $50.20 | -$74.32K | SELL-OPTIONS | 0.00% | 230.31K | Aug 13 | ||
Aug 05, 2009 | DIRECTOR | 0.00 | $41.83 | -$492.17K | SELL-OPTIONS | 0.00% | 18.63K | Aug 03 | ||
Jul 30, 2009 | SVP & GENERAL COUNSEL | 0.00 | $40.60 | -$1.98M | SELL-OPTIONS | 0.00% | 48.40K | Jul 29 | ||
Jul 29, 2009 | SVP-PATHOLOGY & HOSP. SERVICES | 0.00 | $40.74 | -$726.74K | SELL-OPTIONS | 0.00% | 81.54K | Jul 27 - Jul 28 | ||
Jul 29, 2009 | VP AND CORPORATE CONTROLLER | 0.00 | $36.79 | -$115.27K | SELL-OPTIONS | 0.00% | 12.97K | Jul 27 | ||
Jul 27, 2009 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $40.82 | -$4.48M | SELL-OPTIONS | 0.00% | 230.31K | Jul 23 | ||
Jul 27, 2009 | SVP-PATHOLOGY & HOSP. SERVICES | -4.27K | $56.00 | -$239.34K | SELL | -4.98% | 81.54K | Jul 23 | ||
Jul 27, 2009 | SVP & CHIEF FINANCIAL OFFICER | -31.00K | $42.77 | -$3.81M | SELL | -26.15% | 87.54K | Jul 23 | ||
Mar 19, 2009 | DIRECTOR | -5.75M | $44.55 | -$256.14M | SELL | -15.75% | 30.76M | Mar 17 - Mar 19 | ||
Feb 26, 2009 | SVP-PATHOLOGY & HOSP. SERVICES | -10.00K | $51.10 | -$511.00K | SELL | -10.61% | 84.29K | Feb 24 | ||
Feb 25, 2009 | DIRECTOR | 0.00 | $33.15 | -$434.84K | SELL-OPTIONS | 0.00% | 11.89K | Feb 24 | ||
Feb 23, 2009 | SVP & GENERAL COUNSEL | 0.00 | $45.78 | -$190.77K | SELL-OPTIONS | 0.00% | 45.52K | Feb 19 | ||
Feb 20, 2009 | VP AND CORPORATE CONTROLLER | 3.00 | $38.39 | -$453.13K | SELL-OPTIONS | 0.02% | 12.04K | Feb 18 - Feb 19 | ||
Feb 10, 2009 | SVP-PATHOLOGY & HOSP. SERVICES | -5.00K | $52.25 | -$261.25K | SELL | -5.72% | 82.45K | Feb 06 | ||
Feb 10, 2009 | DIRECTOR | 0.00 | $40.86 | -$467.27K | SELL-OPTIONS | 0.00% | 13.37K | Feb 06 | ||
Feb 04, 2009 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $49.50 | -$5.43K | SELL-OPTIONS | 0.00% | 171.16K | Feb 02 | ||
Nov 14, 2008 | DIRECTOR | -668.00 | $45.95 | -$30.69K | SELL | -10.02% | 6.00K | Nov 13 | ||
Nov 07, 2008 | CHAIRMAN, PRESIDENT & CEO | 0.00 | $47.19 | $0.00 | SELL-OPTIONS | 0.00% | 171.15K | Nov 05 - Nov 06 | ||
Jul 31, 2007 | SR. VICE PRESIDENT & CFO | 0.00 | $48.23 | -$181.92K | SELL-OPTIONS | 0.00% | 68.08K | Jul 27 | ||
Feb 27, 2007 | DIRECTOR | 0.00 | $32.69 | -$3.08M | SELL-OPTIONS | 0.00% | 3.33K | Feb 26 | ||
Feb 27, 2007 | DIRECTOR | 0.00 | $45.47 | -$1.03M | SELL-OPTIONS | 0.00% | 3.33K | Feb 23 | ||
Feb 08, 2007 | VICE PRES. & CONTROLLER | 8.00 | $35.15 | -$526.66K | SELL-OPTIONS | 0.19% | 4.24K | Feb 06 - Feb 07 | ||
Nov 01, 2006 | SVP, DIAGNOSTIC TESTING OPS | 0.00 | $37.32 | -$2.50M | SELL-OPTIONS | 0.00% | 36.04K | Oct 30 | ||
Oct 30, 2006 | DIRECTOR | 1.00K | $49.74 | $49.74K | BUY | 11.68% | 9.56K | Oct 26 | ||
May 24, 2006 | CHAIRMAN, PRESIDENT & CEO | 2.00 | $31.45 | -$4.34M | SELL-OPTIONS | 0.00% | 117.09K | May 22 | ||
May 19, 2006 | DIRECTOR | 4.61K | $36.87 | -$166.08K | SELL-OPTIONS | 138.27% | 7.94K | May 17 | ||
May 15, 2006 | SENIOR VP & GENERAL COUNSEL | -3.06K | $33.94 | -$2.28M | SELL | -42.41% | 4.16K | May 11 - May 12 | ||
May 12, 2006 | SVP & CHIEF FINANCIAL OFFICER | -19.25K | $33.04 | -$4.28M | SELL | -92.01% | 1.67K | May 10 - May 11 | ||
May 12, 2006 | SVP & CHIEF FINANCIAL OFFICER | -19.25K | $33.04 | -$4.28M | SELL | -92.01% | 1.67K | May 10 - May 11 | ||
Feb 24, 2006 | VP, SALES & MARKETING | 12.12K | $41.56 | -$972.42K | SELL-OPTIONS | 445.59% | 14.84K | Feb 22 | ||
Aug 12, 2005 | CONTROLLER | 4.81K | $36.16 | -$736.48K | BUY | ∞ | 2.20K | Aug 10 - Aug 12 | ||
May 18, 2005 | DIRECTOR | -5.00K | $106.24 | -$531.21K | SELL | -83.33% | 1.00K | May 16 | ||
May 13, 2005 | SVP, DIAGNOSTIC TESTING OPS | 0.00 | $59.63 | -$2.91M | SELL-OPTIONS | 0.00% | 21.05K | May 11 | ||
May 13, 2005 | SVP, CHIEF FINANCIAL OFFICER | 60.00 | $59.21 | -$3.42M | SELL-OPTIONS | 0.14% | 42.62K | May 11 | ||
May 03, 2005 | DIRECTOR | 0.00 | $68.36 | -$1.38M | SELL-OPTIONS | 0.00% | 5.15K | May 02 | ||
Feb 10, 2005 | PRESIDENT & CEO | 0.00 | $54.02 | -$5.00M | SELL-OPTIONS | 0.00% | 58.53K | Feb 08 | ||
Feb 02, 2005 | SR. VP, GENERAL COUNSEL | -6.99K | $54.07 | -$2.30M | SELL | -34.26% | 13.42K | Jan 31 - Feb 01 | ||
Feb 02, 2005 | DIRECTOR | 0.00 | $62.59 | -$780.73K | SELL-OPTIONS | 0.00% | 2.61K | Jan 31 | ||
Dec 15, 2004 | 10% OWNER | -2.70M | $94.19 | -$254.31M | SELL | -12.89% | 18.25M | Dec 14 | ||
Dec 10, 2004 | DIRECTOR | -1.00K | $56.11 | -$2.01M | SELL | -0.40% | 248.89K | Dec 08 - Dec 10 | ||
Dec 02, 2004 | DIRECTOR | -1.00K | $55.66 | -$1.98M | SELL | -0.40% | 249.89K | Dec 01 | ||
Nov 26, 2004 | DIRECTOR | -56.00K | $54.84 | -$1.94M | SELL | -18.25% | 250.89K | Nov 23 - Nov 24 | ||
Nov 18, 2004 | DIRECTOR | -1.00K | $54.86 | -$1.94M | SELL | -0.32% | 306.89K | Nov 17 | ||
Nov 12, 2004 | DIRECTOR | -1.00K | $54.38 | -$1.92M | SELL | -0.32% | 307.89K | Nov 10 | ||
Nov 04, 2004 | DIRECTOR | -1.00K | $53.04 | -$1.85M | SELL | -0.32% | 308.89K | Nov 03 | ||
Oct 28, 2004 | DIRECTOR | -1.00K | $52.09 | -$1.80M | SELL | -0.32% | 309.89K | Oct 27 | ||
Oct 21, 2004 | DIRECTOR | -1.00K | $51.04 | -$1.74M | SELL | -0.32% | 310.89K | Oct 20 | ||
Oct 14, 2004 | DIRECTOR | -1.00K | $49.30 | -$1.89M | SELL | -0.32% | 311.89K | Oct 13 | ||
Oct 07, 2004 | DIRECTOR | -1.00K | $50.57 | -$1.96M | SELL | -0.32% | 312.89K | Oct 06 | ||
Oct 01, 2004 | DIRECTOR | -1.00K | $50.25 | -$1.94M | SELL | -0.32% | 313.89K | Sep 29 | ||
Sep 23, 2004 | DIRECTOR | -1.00K | $49.15 | -$1.88M | SELL | -0.32% | 314.89K | Sep 22 | ||
Sep 16, 2004 | DIRECTOR | -1.00K | $48.66 | -$1.86M | SELL | -0.32% | 315.89K | Sep 15 | ||
Sep 09, 2004 | DIRECTOR | -1.00K | $49.33 | -$1.89M | SELL | -0.31% | 316.89K | Sep 08 | ||
Sep 01, 2004 | DIRECTOR | -1.00K | $49.80 | -$1.92M | SELL | -0.31% | 317.89K | Sep 01 | ||
Aug 27, 2004 | DIRECTOR | -1.00K | $48.35 | -$1.84M | SELL | -0.31% | 318.89K | Aug 25 | ||
Aug 19, 2004 | DIRECTOR | -1.00K | $48.67 | -$1.86M | SELL | -0.31% | 319.87K | Aug 18 | ||
Aug 17, 2004 | SVP, DIAGNOSTIC TESTING OPS | 0.00 | $47.64 | -$596.25K | SELL-OPTIONS | 0.00% | 20.98K | Aug 13 | ||
Aug 11, 2004 | DIRECTOR | -1.00K | $47.41 | -$1.79M | SELL | -0.31% | 320.87K | Aug 11 | ||
Aug 05, 2004 | DIRECTOR | -1.00K | $47.00 | -$1.77M | SELL | -0.31% | 321.87K | Aug 04 | ||
Jul 29, 2004 | DIRECTOR | -1.00K | $47.06 | -$1.78M | SELL | -0.31% | 322.87K | Jul 28 | ||
Jul 22, 2004 | DIRECTOR | -1.00K | $48.54 | -$1.85M | SELL | -0.31% | 323.87K | Jul 21 | ||
Jul 16, 2004 | DIRECTOR | -1.00K | $48.83 | -$1.87M | SELL | -0.31% | 324.87K | Jul 14 | ||
Jul 08, 2004 | DIRECTOR | -1.00K | $48.86 | -$1.87M | SELL | -0.31% | 325.87K | Jul 07 | ||
Jul 01, 2004 | DIRECTOR | -1.00K | $48.29 | -$1.84M | SELL | -0.30% | 326.87K | Jun 30 | ||
Jun 29, 2004 | 10% OWNER | -1.18M | $86.13 | -$101.33M | SELL | -5.32% | 20.95M | Jun 25 | ||
Jun 24, 2004 | DIRECTOR | -1.00K | $49.68 | -$1.91M | SELL | -0.30% | 327.87K | Jun 23 | ||
Jun 17, 2004 | DIRECTOR | -1.00K | $50.58 | -$1.96M | SELL | -0.30% | 328.87K | Jun 16 | ||
Jun 10, 2004 | DIRECTOR | -1.00K | $50.43 | -$1.95M | SELL | -0.30% | 329.87K | Jun 09 | ||
Jun 02, 2004 | DIRECTOR | -1.00K | $50.38 | -$1.95M | SELL | -0.30% | 330.87K | Jun 02 | ||
May 28, 2004 | DIRECTOR | -1.00K | $49.08 | -$1.88M | SELL | -0.30% | 331.87K | May 26 | ||
May 20, 2004 | DIRECTOR | -1.00K | $47.69 | -$1.81M | SELL | -0.30% | 332.87K | May 19 | ||
May 18, 2004 | PRESIDENT AND CEO | -28.15K | $46.05 | -$4.32M | SELL | -32.48% | 58.52K | May 14 - May 17 | ||
May 13, 2004 | DIRECTOR | 4.00K | $82.06 | $328.23K | BUY | ∞ | 1.00K | May 12 - May 13 | ||
May 12, 2004 | DIRECTOR | 11.69K | $46.42 | -$1.74M | SELL-OPTIONS | 3.63% | 333.87K | May 11 - May 12 | ||
May 07, 2004 | CORP.VP & CHIEF FIN. OFFICER | 16.00 | $48.94 | -$2.00M | SELL-OPTIONS | 0.04% | 42.08K | May 06 | ||
May 06, 2004 | DIRECTOR | 10.00K | $58.03 | $580.31K | SELL-OPTIONS | ∞ | 0.00 | May 06 | ||
May 06, 2004 | DIRECTOR | -1.00K | $49.15 | -$1.88M | SELL | -0.31% | 322.17K | May 05 | ||
May 04, 2004 | VP & CORPORATE CONTROLLER | -2.44K | $85.00 | -$207.66K | SELL | -92.15% | 208.00 | May 03 | ||
May 04, 2004 | DIRECTOR | -1.96K | $48.68 | -$1.96M | SELL | -0.60% | 323.17K | Apr 30 - May 01 | ||
Apr 28, 2004 | DIRECTOR | 0.00 | $55.52 | -$1.42M | SELL-OPTIONS | 0.00% | 2.61K | Apr 27 | ||
Apr 28, 2004 | DIRECTOR | -9.61K | $85.33 | -$820.23K | SELL | -100.00% | 0.00 | Apr 26 - Apr 28 | ||
Mar 17, 2004 | CHAIRMAN & CEO | -5.00K | $45.06 | -$1.52M | SELL | -1.51% | 326.09K | Mar 16 | ||
Mar 10, 2004 | CHAIRMAN & CEO | -5.00K | $44.67 | -$2.24M | SELL | -1.49% | 331.09K | Mar 09 | ||
Mar 04, 2004 | CHAIRMAN & CEO | -5.00K | $44.56 | -$2.23M | SELL | -1.47% | 336.09K | Mar 02 | ||
Mar 02, 2004 | SVP, DIAGNOSTIC TESTING OPS | -2.21K | $48.02 | -$1.58M | SELL | -9.56% | 20.94K | Feb 27 - Feb 28 | ||
Feb 25, 2004 | SVP, ADMINISTRATION | -3.28K | $46.73 | -$1.61M | SELL | -5.67% | 54.56K | Feb 24 | ||
Feb 25, 2004 | CHAIRMAN & CEO | -5.00K | $44.05 | -$2.20M | SELL | -1.44% | 342.05K | Feb 24 | ||
Feb 23, 2004 | DIRECTOR | 15.00 | $46.63 | -$597.69K | SELL-OPTIONS | 0.57% | 2.63K | Feb 20 | ||
Feb 19, 2004 | DIRECTOR | -150.00 | $82.90 | -$12.44K | SELL | -5.43% | 2.61K | Feb 18 | ||
Feb 18, 2004 | CHAIRMAN & CEO | -5.00K | $45.17 | -$2.27M | SELL | -1.42% | 347.05K | Feb 17 | ||
Feb 11, 2004 | CHAIRMAN & CEO | -5.00K | $46.35 | -$2.34M | SELL | -1.40% | 352.03K | Feb 10 | ||
Feb 11, 2004 | DIRECTOR | 150.00 | $48.88 | -$1.27M | SELL-OPTIONS | 5.74% | 2.76K | Feb 10 | ||
Feb 11, 2004 | DIRECTOR | 147.00 | $48.84 | -$1.26M | SELL-OPTIONS | 2.94% | 5.15K | Feb 09 | ||
Feb 11, 2004 | DIRECTOR | -3.00K | $84.96 | -$254.89K | SELL | -23.79% | 9.61K | Feb 09 - Feb 10 | ||
Feb 09, 2004 | DIRECTOR | -4.00K | $84.61 | -$338.42K | SELL | -24.08% | 12.61K | Feb 06 | ||
Feb 05, 2004 | DIRECTOR | -9.00K | $84.97 | -$764.77K | SELL | -35.14% | 16.61K | Feb 03 - Feb 04 | ||
Feb 04, 2004 | CHAIRMAN & CEO | -5.00K | $46.25 | -$2.33M | SELL | -1.38% | 357.03K | Feb 03 | ||
Feb 02, 2004 | DIRECTOR | 23.00K | $52.55 | -$302.60K | SELL-OPTIONS | 880.55% | 25.61K | Jan 29 - Jan 30 | ||
Feb 02, 2004 | CHAIRMAN & CEO | -5.96K | $45.13 | -$2.35M | SELL | -1.62% | 362.03K | Jan 29 - Feb 01 | ||
Jan 30, 2004 | CORP VP, LEGAL & COMPLIANCE | 138.00 | $47.73 | -$1.96M | SELL-OPTIONS | 0.61% | 22.92K | Jan 29 | ||
Jan 30, 2004 | VP&CORPORATE CONTROLLER | -4.27K | $81.76 | -$349.09K | SELL | -56.63% | 3.27K | Jan 29 | ||
Dec 17, 2003 | CHAIRMAN & CEO | -5.00K | $39.34 | -$1.92M | SELL | -1.34% | 368.96K | Dec 16 | ||
Dec 10, 2003 | CHAIRMAN & CEO | -5.00K | $39.75 | -$1.94M | SELL | -1.32% | 373.96K | Dec 09 | ||
Dec 02, 2003 | CHAIRMAN & CEO | -5.99K | $40.86 | -$2.08M | SELL | -1.56% | 378.96K | Dec 01 - Dec 02 | ||
Nov 26, 2003 | CHAIRMAN & CEO | -7.49K | $40.96 | -$1.92M | SELL | -1.91% | 384.95K | Nov 25 | ||
Nov 21, 2003 | CHAIRMAN & CEO | -5.00K | $41.85 | -$1.79M | SELL | -1.26% | 392.43K | Nov 20 | ||
Nov 17, 2003 | DIRECTOR | 0.00 | $39.02 | -$557.73K | SELL-OPTIONS | 0.00% | 2.61K | Nov 14 | ||
Aug 20, 2003 | SVP, ADMINISTRATION | -4.00 | $35.91 | -$1.14M | SELL | -0.01% | 57.84K | Aug 20 | ||
Aug 07, 2003 | DIRECTOR | 2.00K | $57.56 | $115.12K | BUY | ∞ | 2.00K | Aug 06 | ||
Jul 30, 2003 | SR. VP -DIAGNOSTIC TESTG OPS | -15.23K | $60.71 | -$924.91K | SELL | -39.69% | 23.15K | Jul 29 - Jul 30 | ||
Jul 29, 2003 | DIRECTOR | 0.00 | $33.63 | -$460.80K | SELL-OPTIONS | 0.00% | 2.61K | Jul 25 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.